via boston.com
The Cambridge biotechnology giant said yesterday that the Food and Drug Administration notified it Tuesday that the agency plans to take “enforcement action’’ against the company.
It marks the first time Genzyme has faced an FDA fine in its 29-year history and comes four months after the company said some of the drugs processed at the plant were contaminated by bits of steel, rubber, and fiber.
No comments:
Post a Comment